Corazon Sanders
Director/Board Member presso MOLECULAR TEMPLATES, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Oyler | M | 56 | 14 anni | |
| Jason Kim | M | 49 | 14 anni | |
| Eric Poma | M | 52 | 24 anni | |
| Fang Liang Zhang | M | 59 | 8 anni | |
| Emil Kakkis | M | 63 | 14 anni | |
| Xiao Dong Wang | M | 61 | 14 anni | |
| Judy Chou | M | 58 |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | - |
| Leewen Lin | M | - |
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Lori Macomber | F | 53 | 5 anni | |
| Julia Wang | F | 53 | 4 anni | |
| Daniel Welch | M | 66 | 9 anni | |
| Gabriela Gruia | M | 67 | 2 anni | |
| Patrick Yang | M | 75 |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou.
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | 3 anni |
| Ying Huang | M | 51 | 5 anni | |
| Tomas Jan Heyman | M | 68 | 2 anni | |
| Anthony Hooper | M | 69 | 4 anni | |
| Ranjeev Krishana | M | 50 | 10 anni | |
| Ye Wang | F | 55 | 9 anni | |
| Xiao Bin Wu | M | 62 | 6 anni | |
| Eric Crombez | M | - | 7 anni | |
| Shehnaaz Suliman | M | 52 | 5 anni | |
| Qing Qing Yi | M | 52 | 10 anni | |
| Wendy Yan | F | 58 | 10 anni | |
| Kristen Quigley | F | 53 | 7 anni | |
| Wai Man Yau | M | 48 | 4 anni | |
| Donald Glazer | M | 79 | 11 anni | |
| Xiao Hui Ji | M | 62 | 4 anni | |
| Lai Wang | M | 47 | 13 anni | |
| Crystal Chen | F | - | 3 anni | |
| Amrit Ray | M | 51 | 2 anni | |
| Margaret Dugan | M | 67 | 2 anni | |
| Li Mao | M | 67 | 2 anni | |
| Alessandro Riva | M | 63 | 2 anni | |
| Patrick J. Casey | M | 68 | 4 anni | |
| Matthew Fust | M | 59 | 10 anni | |
| Scott Samuels | M | 54 | - | |
| Kevin Lalande | M | 51 | 15 anni | |
| Ruth C. S. Li | M | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Olivier Brandicourt | M | 68 | - | |
| David Hoffmann | M | 79 | 7 anni | |
| Shih-Yao Lin | M | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Michael Narachi | M | 64 | 9 anni | |
| Deborah Dunsire | M | 61 | 7 anni | |
| Harold Selick | M | 69 | 7 anni | |
| Michael Goller | M | 49 | 9 anni | |
| Yan Liu | M | - | 5 anni | |
| John C. Doyle | M | 55 |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | - |
| Yuhong Qiu | M | - | 6 anni | |
| Erik Harris | M | 54 | 7 anni | |
| Stephen G. Juelsgaard | M | 75 |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | - |
| Clare Fisher | F | 51 | 3 anni | |
| Eva Yin | F | - | - | |
| Guowei Fang | M | - | 2 anni | |
| Graham Hardiman | M | - | 3 anni | |
| Liz Gosen | F | - | 5 anni | |
| Thomas Kassberg | M | 63 | 13 anni | |
| Joshua Higa | M | - | - | |
| Tracy Luo | M | - | 6 anni | |
| Theodore Huizenga | M | 53 | 10 anni | |
| Guillaume Vignon | M | - | 6 anni | |
| Steven J. Gavel | M | - | 6 anni | |
| Dennis Huang | M | 59 | 9 anni | |
| Yung-Hua Chung | M | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Hazel T. Y. Cheng | M | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Vimal Srivastava | M | 58 | 13 anni | |
| Sean Bohen | M | 58 |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | 5 anni |
| Be-Sheng Kuo | M | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| Samuel C. Wadsworth | M | 75 | 7 anni | |
| Li Zhu | M | 74 | 4 anni | |
| Jason W. Radford | M | 42 | 4 anni | |
| Ernie Meyer | M | 60 | 4 anni | |
| Julius Pryor | M | - | 1 anni | |
| Karah Parschauer | F | 46 | 8 anni | |
| Chia-Jung Yang | F | - |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | - |
| John Pinion | M | 58 | 9 anni | |
| Jessie Yeung | F | - | 5 anni | |
| Howard Horn | M | 47 | 1 anni | |
| Liza Heapes | F | - | - | |
| Elaine Qian | F | - | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Adam Daniel Cutler | M | 50 | 4 anni | |
| Robert Nelsen | M | 60 | 5 anni | |
| Howard H. Pien | M | 66 | 4 anni | |
| Maggie Wilderotter | F | 69 | 4 anni | |
| Bill Aliski | M | 75 | 11 anni | |
| Yong Ben | M | 50 | 3 anni | |
| Jonathan Lanfear | M | 55 | 6 anni | |
| Danielle Keatley | F | - | 5 anni | |
| Scott Morenstein | M | 48 | 6 anni | |
| Yung Cheng Chen | M | 67 | 6 anni | |
| Lars Ekman | M | 74 | 7 anni | |
| Hal Barron | M | 62 | 4 anni | |
| sam Su | M | 71 | 4 anni | |
| Thomas Daniel | M | 69 | 3 anni | |
| Richard Klausner | M | 72 | 5 anni | |
| David Hirsch | M | 53 | 6 anni | |
| Thomas Malley | M | 55 | 8 anni | |
| Sean McLennan | M | 54 | 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 70 | 72.16% |
| Isole Cayman | 27 | 27.84% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Corazon Sanders
- Contatti personali
